Voyageur Pharmaceuticals Ltd (VM.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
| 11-2019 | 11-2018 | 11-2017 | 12-2016 | 11-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 76 | 147 | 17 | 697 | 2 |
| Receivables | 96 | 80 | 75 | 12 | 16 |
| Inventories | 10 | N/A | N/A | N/A | N/A |
| TOTAL | $397 | $229 | $92 | $709 | $17 |
| Non-Current Assets | |||||
| PPE Net | 1,196 | 1,023 | 764 | N/A | 191 |
| Other Non-Current Assets | 14 | 14 | 14 | 0 | 14 |
| TOTAL | $1,210 | $1,037 | $778 | $0 | $205 |
| Total Assets | $1,607 | $1,266 | $870 | $709 | $222 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 105 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 651 | 498 | N/A | N/A | N/A |
| Other current liabilities | N/A | N/A | N/A | N/A | 6 |
| TOTAL | $815 | $566 | $589 | $39 | $242 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 138 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 14 | 14 | 329 | 0 | 284 |
| TOTAL | $38 | $185 | $370 | $0 | $284 |
| Total Liabilities | $853 | $751 | $959 | $39 | $526 |
| Shareholders' Equity | |||||
| Common Shares | 3,036 | 2,331 | 0 | 0 | 0 |
| Retained earnings | -2,783 | -2,231 | -1,675 | -279 | -1,004 |
| Other shareholders' equity | 0 | 0 | 135 | 696 | 0 |
| TOTAL | $754 | $516 | $-89 | $670 | $-304 |
| Total Liabilities And Equity | $1,607 | $1,266 | $870 | $709 | $222 |